ArticleCancers2023

Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal.

Mariusz L Hartman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.